| 2-Pyridinamine, 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- |
(S)-CRIZOTINIB |
1374356-45-2 |
| BAR 502 |
BAR 502 |
1612191-86-2 |
| MAK-683 |
CPD 1111 |
1951408-58-4 |
| HG-14-10-04 |
CS-1175 |
1356962-34-9 |
| Mal-PEG2-acid |
马来酰亚胺-二聚乙二醇-羧酸 |
1374666-32-6 |
| Benzene,1,3,5-trimethyl-2-[(4-methylphenyl)sulfonyl]- |
ESI-05 |
5184-64-5 |
| DCLK1-IN-1 |
DCLK1-IN-1 |
2222635-15-4 |
| kobe-2602 |
KOBE-2602 |
454453-49-7 |
| E-7449 |
1140964-99-3 |
1140964-99-3 |
| NSC 55712 |
NSC 55712 |
2076-91-7 |
| 5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine |
GNE-317 |
1394076-92-6 |
| RO8994 |
RO 8994 |
1309684-94-3 |
| (S)-2-(8-(2-(6-(methylamino)pyridin-2-yl)ethoxy)-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid |
SB273005 INTEGRIN抑制剂 |
205678-31-5 |
| Anamorelin |
阿拉莫林 |
249921-19-5 |
| Cabotegravir (GSK744, GSK1265744) |
卡博特韦 |
1051375-10-0 |
| Azido-PEG4-NHBoc |
叠氮-四聚乙二醇-叔丁氧羰基 |
642091-68-7 |
| VTP50469 |
VTP50469 |
2169916-18-9 |
| CC-122 |
3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 |
1015474-32-4 |
| Tenuifoliside C |
远志糖苷C |
139726-37-7 |
| Gboxin |
Gboxin |
2101315-36-8 |
